Wall St Warrior

Retail investors buy Novo dip after disappointing weight-loss drug data

By Bhanvi Satija (Reuters) – U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker’s weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research. Daily net flows climbed to $15.6 million from $0.49 million a day earlier, after eagerly anticipated data showed Novo’s experimental drug,…

Read More

US crypto industry eyes possible day-one Trump executive orders

By Hannah Lang (Reuters) – The cryptocurrency industry is pushing President-elect Donald Trump’s team to kick start his promised crypto policy overhaul when he takes office next month with executive orders that would help push tokens mainstream, according to industry officials. Trump plans to issue a flurry of executive orders and directives on everything from…

Read More

Exclusive-Microsoft works to add non-OpenAI models into 365 Copilot products, sources say

By Anna Tong and Krystal Hu Microsoft has been working on adding internal and third-party artificial intelligence models to power its flagship AI product Microsoft 365 Copilot, in a bid to diversify from the current underlying technology from OpenAI and reduce costs, sources familiar with the effort told Reuters. It is the latest effort by…

Read More

Polish e-commerce Allegro’s unit sues Alphabet for $568 million

By Mateusz Rabiega GDANSK (Reuters) -A subsidiary of Polish e-commerce platform Allegro filed a lawsuit on Monday against Google owner Alphabet, Google Ireland and Google LLC, seeking 2.33 billion zlotys ($567.60 million) in damages, Allegro said in a statement. The unit, Ceneo, is demanding compensation for losses it says it suffered due to Google’s practices…

Read More

Ford donates $1 million and fleet of vehicles to Trump’s inauguration

By Nora Eckert and David Shepardson DETROIT (Reuters) – Ford Motor Co is donating $1 million and a fleet of vehicles to U.S. President-elect Donald Trump’s January inauguration, a company spokesperson said on Monday. Policies on tariffs and electric vehicles that are being considered by the incoming administration would likely affect Detroit carmakers like Ford,…

Read More

Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder. The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company…

Read More